Overview

The Pharmacokinetics of Fentanyl in Intensive Care Patients

Status:
Unknown status
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
This study is part of a project intended to develop guidelines to optimise the dosing of fentanyl in intensive care patients. This study will focus on determining: - Whether the pharmacokinetics of fentanyl change during the ICU stay. - To what extent / the degree of change in fentanyl pharmacokinetics in ICU patients. - Which factors (e.g. physiological variables) that cause such a change. - Based on simulations, determine context-sensitive half-times of fentanyl in ICU patients.
Phase:
Phase 4
Details
Lead Sponsor:
Oslo University Hospital
Collaborator:
University of California
Treatments:
Fentanyl